Fundamental deficiencies in the megatrial methodology

Article


Charlton, Bruce G. 2001. Fundamental deficiencies in the megatrial methodology. Current controlled trials in cardiovascular medicine. 2 (1), pp. 2-7.
AuthorsCharlton, Bruce G.
Abstract

The fundamental methodological deficiency of megatrials is deliberate reduction of experimental control in order to maximize recruitment and compliance of subjects. Hence, typical megatrials recruit pathologically and prognostically heterogeneous subjects, and protocols typically fail to exclude significant confounders. Therefore, most megatrials do not test a scientific hypothesis, nor are they informative about individual patients. The proper function of a megatrial is precise measurement of effect size for a therapeutic intervention. Valid megatrials can be designed only when simplification can be achieved without significantly affecting experimental control. Megatrials should be conducted only at the end of a long process of therapeutic development, and must always be designed and interpreted in the context of relevant scientific and clinical information.

Keywordsepidemiology; history; megatrial; methodology; randomized trial; therapeutic intervention
JournalCurrent controlled trials in cardiovascular medicine
Journal citation2 (1), pp. 2-7
ISSN1745-6215
Year2001
Publisher's version
License
CC BY-ND
Web address (URL)http://hdl.handle.net/10552/250
Publication dates
PrintJan 2001
Publication process dates
Deposited11 Aug 2009
Additional information

Citation:
Charlton, B. G. (2001) ‘Fundamental deficiencies in the megatrial methodology.’ Current controlled trials in cardiovascular medicine 2(1) 2-7.

Permalink -

https://repository.uel.ac.uk/item/869xw

Download files


Publisher's version
  • 19
    total views
  • 17
    total downloads
  • 0
    views this month
  • 0
    downloads this month

Export as